Senator Hassan Questions FDA on Designation of Certain Opioids as “Abuse Deterrent”

Senator Hassan participated in the Health, Education, Labor, and Pensions Committee hearing where she questioned an FDA official on the designation of certain opioids as “abuse-deterrent” and pushed the FDA to engage in efforts to combat the substance misuse crisis. Senator Hassan pointed out that the designation of certain opioids as “abuse deterrent” is misleading because these products are just as addictive as other opioids.